Invention Grant
- Patent Title: Methods of intravenous administration of glyburide
- Patent Title (中): 静脉注射格列本脲的方法
-
Application No.: US14878232Application Date: 2015-10-08
-
Publication No.: US09561176B2Publication Date: 2017-02-07
- Inventor: Sven Martin Jacobson
- Applicant: Remedy Pharmaceuticals, Inc.
- Applicant Address: US NY New York
- Assignee: Remedy Pharmaceuticals, Inc.
- Current Assignee: Remedy Pharmaceuticals, Inc.
- Current Assignee Address: US NY New York
- Agency: Thorpe North & Western LLP
- Main IPC: A61K31/17
- IPC: A61K31/17 ; A61K9/00 ; A61K31/64 ; A61K31/18

Abstract:
The present disclosure is drawn to a method of treating a patient in need of treatment, comprising identifying a patient in need of treatment for stroke, traumatic brain injury, spinal cord injury, myocardial infarction, shock, organ ischemia, ventricular arrhythmias, ischemic injury, or hypoxia/ischemia; administering a bolus of glyburide to the patient; and administering a continuous infusion of glyburide to the patient at from about 15 μg/hr and about 300 μg/hr, wherein the continuous infusion glyburide is administered for a period of time more than about 20 hours.
Public/Granted literature
- US20160030370A1 METHODS OF INTRAVENOUS ADMINISTRATION OF GLYBURIDE Public/Granted day:2016-02-04
Information query